Novel glucocorticoids: current status and challenges

Area of Science:

• Rheumatology
• Pharmacology
• Immunology

Background:

• Glucocorticoids are essential but toxic treatments for inflammatory diseases.
• Reducing glucocorticoid toxicity is a major clinical challenge.
• Current treatments often involve a trade-off between efficacy and adverse effects.

Purpose of the Study:

• To review novel approaches for reducing glucocorticoid toxicity in rheumatology.
• To discuss strategies for optimizing glucocorticoid use and developing alternatives.
• To highlight the importance of documenting glucocorticoid-induced toxicity.

Main Methods:

• Review of current research on novel glucocorticoid receptor (GR) ligands.
• Analysis of selective GR agonists and modulators (SEGRAMs).
• Examination of targeted delivery systems and combination therapies (e.g., prednisone with 11beta-HSD-1 inhibitors).

Main Results:

• Development of SEGRAMs and targeted delivery methods show promise.
• Combination therapies offer potential for reduced glucocorticoid dosage.
• Optimizing glucocorticoid use requires careful benefit-risk assessment.

Conclusions:

• Novel therapeutic strategies are emerging to mitigate glucocorticoid toxicity.
• Glucocorticoid-sparing approaches are crucial for managing inflammatory diseases.
• Continued research and documentation are vital for developing safer alternatives.